AU8796491A - Pyridyl derivatives - Google Patents

Pyridyl derivatives

Info

Publication number
AU8796491A
AU8796491A AU87964/91A AU8796491A AU8796491A AU 8796491 A AU8796491 A AU 8796491A AU 87964/91 A AU87964/91 A AU 87964/91A AU 8796491 A AU8796491 A AU 8796491A AU 8796491 A AU8796491 A AU 8796491A
Authority
AU
Australia
Prior art keywords
thromboxane
addition
addition salts
pyridyl derivatives
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU87964/91A
Other versions
AU640063B2 (en
Inventor
Wolfgang Eisert
Thomas Muller
Rainer Soyka
Johannes Weisenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of AU8796491A publication Critical patent/AU8796491A/en
Application granted granted Critical
Publication of AU640063B2 publication Critical patent/AU640063B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Paper (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to novel pyridyl derivatives of the general formula <IMAGE> in which R1 to R6, A, X and n are as defined in Claim 1, their enantiomers, their cis- and trans-isomers if R4 and R5 together represent a carbon-carbon bond, and their addition salts, for pharmaceutical use, in particular, their physiologically tolerable addition salts with inorganic or organic bases, if R6 represents a hydroxyl group, which have useful pharmacological properties, in particular antithrombotic effects and effects mediated by thromboxane. In addition, the novel compounds are at the same time thromboxane antagonists (TRA) and thromboxane synthesis inhibitors (TSH). In addition, they also have an effect on PGE2 production.
AU87964/91A 1990-11-22 1991-11-19 Pyridyl derivatives Ceased AU640063B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4037112A DE4037112A1 (en) 1990-11-22 1990-11-22 NEW PYRIDYL DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE4037112 1990-11-22

Publications (2)

Publication Number Publication Date
AU8796491A true AU8796491A (en) 1992-05-28
AU640063B2 AU640063B2 (en) 1993-08-12

Family

ID=6418696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87964/91A Ceased AU640063B2 (en) 1990-11-22 1991-11-19 Pyridyl derivatives

Country Status (19)

Country Link
EP (1) EP0487095B1 (en)
JP (1) JPH04275273A (en)
KR (1) KR920009799A (en)
AT (1) ATE134619T1 (en)
AU (1) AU640063B2 (en)
CA (1) CA2055950A1 (en)
DE (2) DE4037112A1 (en)
DK (1) DK0487095T3 (en)
ES (1) ES2084756T3 (en)
FI (1) FI915484A (en)
GR (1) GR3019783T3 (en)
HU (1) HU213676B (en)
IE (1) IE74248B1 (en)
IL (1) IL100097A (en)
NO (1) NO175634C (en)
NZ (1) NZ240677A (en)
PT (1) PT99571B (en)
RU (1) RU2028292C1 (en)
ZA (1) ZA919205B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4216364A1 (en) * 1991-12-14 1993-11-25 Thomae Gmbh Dr K Pyridyl derivs. with antithrombotic properties
AR028110A1 (en) * 2000-06-02 2003-04-23 Astrazeneca Ab NEW PROCESS
DE10225635C1 (en) * 2002-06-07 2003-12-24 Aventis Pharma Gmbh N-benzoylureido-cinnamic acid derivatives, process for their preparation and their use
FI20055498A0 (en) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamides
US20150315130A1 (en) * 2012-12-10 2015-11-05 H. Lundbeck A/S New positive allosteric modulators of nicotinic acetylcholine receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518602A (en) * 1982-10-07 1985-05-21 Takeda Chemical Industries, Ltd. Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
DE3932403A1 (en) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K NEW ARYLSULFONAMIDES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
ZA919205B (en) 1993-05-21
EP0487095A1 (en) 1992-05-27
JPH04275273A (en) 1992-09-30
DE59107462D1 (en) 1996-04-04
ES2084756T3 (en) 1996-05-16
IE74248B1 (en) 1997-07-16
AU640063B2 (en) 1993-08-12
GR3019783T3 (en) 1996-07-31
RU2028292C1 (en) 1995-02-09
HU913644D0 (en) 1992-02-28
NZ240677A (en) 1994-12-22
FI915484A (en) 1992-05-23
NO914567D0 (en) 1991-11-21
HU213676B (en) 1997-09-29
IE914048A1 (en) 1992-06-03
IL100097A0 (en) 1992-08-18
DK0487095T3 (en) 1996-06-24
PT99571B (en) 1999-04-30
EP0487095B1 (en) 1996-02-28
CA2055950A1 (en) 1992-05-23
HUT60472A (en) 1992-09-28
NO175634C (en) 1994-11-09
PT99571A (en) 1992-10-30
DE4037112A1 (en) 1992-05-27
FI915484A0 (en) 1991-11-21
KR920009799A (en) 1992-06-25
ATE134619T1 (en) 1996-03-15
NO914567L (en) 1992-05-25
IL100097A (en) 1995-07-31
NO175634B (en) 1994-08-01

Similar Documents

Publication Publication Date Title
AU5492490A (en) Arylsulphonamides
AU3005892A (en) Pyridyl derivatives
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
EP1329218A4 (en) Preventives/remedies for portal hypertension
AU640063B2 (en) Pyridyl derivatives
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
EP0189916A3 (en) 3-(pyrrolidinio)methyl-3-cephem derivatives, pharmaceutical composition and process for the production thereof
ATE100102T1 (en) SUBSTITUTED DERIVATIVES OF 20,21DINOREBUNAMENINE, PROCESSES FOR THE MANUFACTURE AND INTERMEDIATE PRODUCTS SO MANUFACTURED, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DK0521766T3 (en) New method for synthesis of enantiomers of 3-aminochromane derivatives
FR2655042B1 (en) NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE59106666D1 (en) BICYCLO [3.3.0] OCTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE.

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired